Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Heidelberg Materials North America Celebrates 10th Anniversary of Winyah STAR® Plant Commercial Operations
-
Sonatype Expands Enterprise Protection Against Open Source Malware
-
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
-
Sphera’s 2025 Scope 3 Report Reveals Sustainability Progress Despite Persistent Data Challenges
-
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ready Capital Corporation of Class Action Lawsuit and Upcoming Deadlines - RC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fluence Energy, Inc. of Class Action Lawsuit and Upcoming Deadlines - FLNC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BigBear.ai Holdings, Inc. - BBAI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TFI International Inc. of Class Action Lawsuit and Upcoming Deadlines - TFII
-
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
-
authID Announces Strategic Partnership with TechDemocracy to Accelerate Passwordless Identity for Workforce & Customer Access
-
Mark43 and Flock Safety Announce Partnership to Seamlessly Integrate Crime-Fighting Solutions, Supporting Safer Communities
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers – CAR
-
SRM Entertainment Awarded Three New Global Theme Park Toy Programs Based on Iconic Movie Franchise
-
MTA Strengthens Global Event Operations to Better Support Customers with Strategic Regional Hubs
-
Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Canopy Growth Corporation and Certain Officers – CGC
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against e.l.f. Beauty, Inc. and Certain Officers – ELF
-
DIRTT to Announce First Quarter 2025 Financial Results on May 7, 2025
-
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025
-
Annovis Bio Appoints Hui Liu as Director of Biostatistics
-
Glass House Brands to Host First Quarter 2025 Conference Call on May 13, 2025
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against SoundHound AI, Inc. and Certain Officers – SOUN
-
BDev Ventures’ Keshia Theobald-van Gent Named 2025 Woman of Influence by Silicon Valley Business Journal
-
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
-
Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025
-
Pomerantz Law Firm Announces the Filing of a Class Action Against NET Power Inc. and Certain Officers – NPWR
-
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
-
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
-
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference
-
BitMEX Introduces Free Bitcoin Spot Trading Until Bitcoin Hits $100,000
-
Vaisala Corporation: Managers’ Transactions – Syrjänen, Tuomas
-
As European carmakers navigate the autonomous car race, Lighty’s new AI edge software offers them a lifeline amid rising tariffs
-
ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkins
-
SUTNTIB AB Tewox audited consolidated and separate annual financial statements for 2024
-
Milliways, the chewing gum revolution, arrives in France
-
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
-
Aveanna to Participate at the RBC 2025 Global Healthcare Conference
-
Hillman Reports First Quarter 2025 Results
-
Repligen Reports First Quarter 2025 Financial Results
-
Fresh From the Desert: Habit Burger & Grill Drops the Desert Drip Char Meal Nationwide
-
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
-
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
-
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
-
DATE CORRECTION – Amerigo will report Q1-2025 Financial Results on May 7, 2025
-
ZenaTech’s ZenaDrone Subsidiary Will Showcase its Drones to US Defense Potential Customers at Major Upcoming Conferences
-
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
